National Digestive Diseases
Information Clearinghouse (NDDIC)

A service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)

pills gardening gloves doctor drawing blood

NIH Study to Test Treatment for Fatty Liver Disease in Children

Photo of children smiling

NIH-funded scientists have launched a new clinical trial called Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease in Children (CyNCh). The trial will enroll 150 boys and girls ages 8 to 17 with nonalcoholic fatty liver disease, in an effort to find a safe and effective treatment that helps children with fatty liver disease. The participants will receive cysteamine or placebo by mouth twice a day for a year. There are no weight cutoffs or percentiles for the children participating in CyNCh. However, more than 90 percent of the children are expected to be overweight or obese. Children with poorly managed diabetes, heart disease, and other chronic liver diseases will be excluded.

Combination Antiviral Therapy is More Effective for Pediatric Chronic Hepatitis C

A clinical trial has shown that combination therapy with peginterferon and ribavirin is more effective than therapy with peginterferon and placebo in treating chronic hepatitis C in children and adolescents. This trial was conducted at 11 sites throughout the United States. Recent US census results show that 23,048 to 42,296 children are chronically infected with the hepatitis C virus. Eradication of the virus in an infected child has the dual benefits of eliminating social stigma as well as the progression of liver disease.

Functioning Bioengineered Anal Sphincters Implanted in Mice

Photo of lab mice

Building on research that may have implications for future treatment for fecal incontinence, scientists have successfully implanted a physiologically functional bioengineered internal anal sphincter (IAS) in mice. The IAS is a ring-like muscle located just inside the rectum; along with the external anal sphincter, these two muscles keep the anus closed and maintain fecal continence. Loss of IAS muscle tone is a primary cause for the uncontrolled release of stool that occurs in people with fecal incontinence, a condition that places devastating emotional, social, physical, and economic burdens on people who are affected by it.


New Publications

 

Page last updated August 20, 2012


The National Digestive Diseases Information Clearinghouse is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

National Digestive Diseases Information Clearinghouse
2 Information Way
Bethesda, MD 20892–3570
Phone: 1–800–891–5389
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: nddic@info.niddk.nih.gov
Internet: www.digestive.niddk.nih.gov

Department of Health and Human Services The National Institutes of Health The National Institute of Diabetes and Digestive and Kidney Diseases USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services. This website is certified by Health On the Net Foundation. Click to verify.

NIH...Turning Discovery Into Health ®

Privacy Statement | Disclaimers | Accessibility | PDF versions require the free Acrobat Reader click to view disclaimer page software for viewing.